Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹139/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Atorable F Tablet combines Atorvastatin Calcium 10mg and Fenofibrate 160mg, offering a synergistic approach to managing mixed dyslipidemia. Atorvastatin, a statin, reduces cholesterol production in the liver by inhibiting the HMG-CoA reductase enzyme, leading to lower LDL (bad cholesterol) and triglycerides, and higher HDL (good cholesterol). Fenofibrate, a fibrate class lipid-modifying agent, primarily targets triglycerides and enhances HDL levels by activating lipoprotein lipase and PPAR-alpha pathways. This combination is especially effective in patients with combined hyperlipidemia and is often used when statin therapy alone is insufficient. Atorable F is recommended along with dietary changes, exercise, and overall cardiovascular risk management.
Patients may experience muscle pain, weakness, headache, abdominal discomfort, or elevated liver enzymes. Rare but serious side effects include rhabdomyolysis, pancreatitis, or liver toxicity. Immediate medical consultation is advised if unexplained muscle pain or jaundice occurs.
Indicated for the treatment of mixed dyslipidemia, especially in patients with high triglycerides and low HDL levels, and for reducing the risk of cardiovascular complications in high-risk individuals.
Use only under medical supervision. Regular monitoring of lipid levels, liver function, and kidney parameters is essential. Caution is advised in patients with liver, kidney, or gallbladder disorders.
Store in a cool, dry place below 25°C. Keep away from direct sunlight and moisture. Ensure the medication is out of reach of children.
Composition : Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsule
Composition : Atorvastatin (10mg) + Aspirin (75mg) Capsule
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Atorvastatin + Fenofibrate Tablet is a high-demand product in the cardiology, diabetology, and chronic care segment, making it a valuable addition to a PCD pharma franchise portfolio. With the increasing prevalence of dyslipidemia, cardiovascular disorders, and metabolic diseases, this combination enjoys strong prescription demand from cardiologists, diabetologists, physicians, hospitals, and healthcare institutions across India.
Medical distributors and franchise partners can benefit from the growing demand for lipid management therapies. Commonly prescribed for the management of abnormal lipid levels under medical supervision Combines two widely used lipid-lowering agents in a single convenient formulation Frequently recommended by cardiologists, diabetologists, and physicians Strong demand across hospitals, clinics, and retail pharmacy channels Long-term therapy contributes to regular repeat prescriptions Supports expansion into the rapidly growing cardiovascular and metabolic care segment This strengthens a comprehensive cardiology and chronic care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Atorvastatin Calcium 10 mg + Fenofibrate 160 mg Tablet with exclusive monopoly rights, promotional support, attractive packaging, and competitive pricing for distributors, stockists, and wholesalers across India.
Wholesalers and medical agencies can benefit from: Strong prescription demand in the cardiology and metabolic care segment High repeat-order potential due to chronic therapy usage Strong acceptance among cardiologists and physicians Reliable product availability and supply chain support Attractive business margins and long-term growth opportunities Expanding cardiovascular healthcare market across India These advantages contribute to sustainable sales growth and business expansion.
Interested distributors, stockists, and pharma entrepreneurs can partner with Cafoli LifeCare Pvt Ltd to access profitable PCD pharma franchise opportunities for Atorvastatin Calcium 10 mg + Fenofibrate 160 mg Tablet. With exclusive monopoly rights, comprehensive promotional support, quality-assured formulations, attractive profit margins, and dependable logistics services, Cafoli LifeCare Pvt Ltd helps franchise partners establish and expand a successful pharmaceutical business across India.